HKD 3.03
(1.0%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -691.45 Million CNY | 21.33% |
2022 | -878.93 Million CNY | -42.17% |
2021 | -618.24 Million CNY | -23.08% |
2020 | -502.33 Million CNY | -248.5% |
2019 | -144.14 Million CNY | -6.94% |
2018 | -134.79 Million CNY | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | -193.42 Million CNY | 0.0% |
2023 Q4 | -353.43 Million CNY | 0.0% |
2023 FY | -691.45 Million CNY | 21.33% |
2023 Q2 | -338.72 Million CNY | 0.0% |
2022 Q2 | -310.41 Million CNY | 0.0% |
2022 FY | -878.93 Million CNY | -42.17% |
2022 Q4 | -568.52 Million CNY | 0.0% |
2021 FY | -618.24 Million CNY | -23.08% |
2021 Q2 | -213.97 Million CNY | 0.0% |
2021 Q4 | -404.26 Million CNY | 0.0% |
2020 Q4 | -265.27 Million CNY | 0.0% |
2020 FY | -502.33 Million CNY | -248.5% |
2020 Q2 | -237.05 Million CNY | 0.0% |
2019 FY | -144.14 Million CNY | -6.94% |
2019 Q4 | -114.7 Million CNY | 0.0% |
2019 Q2 | -29.43 Million CNY | 0.0% |
2018 Q2 | -33.69 Million CNY | 0.0% |
2018 Q4 | -80.73 Million CNY | 0.0% |
2018 Q1 | -33.69 Million CNY | 0.0% |
2018 FY | -134.79 Million CNY | 0.0% |
2017 Q4 | -33.69 Million CNY | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Uni-Bio Science Group Limited | 67.76 Million HKD | 1120.322% |
CK Life Sciences Int'l., (Holdings) Inc. | 897.95 Million HKD | 177.003% |